scholarly journals Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration

2010 ◽  
Vol 49 (4) ◽  
pp. 476-492 ◽  
Author(s):  
Robert S. Molday ◽  
Kang Zhang
2012 ◽  
Vol 6 (5) ◽  
pp. 1045-1049 ◽  
Author(s):  
JUNHUI YI ◽  
SHIQIANG LI ◽  
XIAOYUN JIA ◽  
XUESHAN XIAO ◽  
PANFENG WANG ◽  
...  

2020 ◽  
Vol 41 (11) ◽  
pp. 1944-1956 ◽  
Author(s):  
Susan B. Curtis ◽  
Laurie L. Molday ◽  
Fabian A. Garces ◽  
Robert S. Molday

2020 ◽  
Vol 22 (1) ◽  
pp. 185
Author(s):  
Fabian A. Garces ◽  
Jessica F. Scortecci ◽  
Robert S. Molday

ABCA4 is an ATP-binding cassette (ABC) transporter expressed in photoreceptors, where it transports its substrate, N-retinylidene-phosphatidylethanolamine (N-Ret-PE), across outer segment membranes to facilitate the clearance of retinal from photoreceptors. Mutations in ABCA4 cause Stargardt macular degeneration (STGD1), an autosomal recessive disorder characterized by a loss of central vision and the accumulation of bisretinoid compounds. The purpose of this study was to determine the molecular properties of ABCA4 variants harboring disease-causing missense mutations in the transmembrane domains. Thirty-eight variants expressed in culture cells were analyzed for expression, ATPase activities, and substrate binding. On the basis of these properties, the variants were divided into three classes: Class 1 (severe variants) exhibited significantly reduced ABCA4 expression and basal ATPase activity that was not stimulated by its substrate N-Ret-PE; Class 2 (moderate variants) showed a partial reduction in expression and basal ATPase activity that was modestly stimulated by N-Ret-PE; and Class 3 (mild variants) displayed expression and functional properties comparable to normal ABCA4. The p.R653C variant displayed normal expression and basal ATPase activity, but lacked substrate binding and ATPase activation, suggesting that arginine 653 contributes to N-Ret-PE binding. Our classification provides a basis for better understanding genotype–phenotype correlations and evaluating therapeutic treatments for STGD1.


Sign in / Sign up

Export Citation Format

Share Document